Tourmaline Bio, Inc. (TRML)
Oct 28, 2025 - TRML was delisted (reason: acquired by NVS)
47.98
0.00 (0.00%)
Inactive ยท Last trade price on Oct 27, 2025
Tourmaline Bio Employees
Tourmaline Bio had 74 employees as of December 31, 2024. The number of employees increased by 30 or 68.18% compared to the previous year.
Employees
74
Change (1Y)
30
Growth (1Y)
68.18%
Revenue / Employee
n/a
Profits / Employee
-$1,195,595
Market Cap
1.24B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 74 | 30 | 68.18% |
| Dec 31, 2023 | 44 | - | - |
TRML News
- 1 year ago - Novartis completes acquisition of Tourmaline Bio - GlobeNewsWire
- 1 year ago - Novartis announces expiration of Tourmaline Bio tender offer - GlobeNewsWire
- 1 year ago - Novartis announces expiration of Hart-Scott-Rodino waiting period of Tourmaline Bio tender offer - GlobeNewsWire
- 1 year ago - Tourmaline Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Tourmaline Bio, Inc. - TRML - Business Wire
- 1 year ago - Novartis announces commencement of tender offer to acquire Tourmaline Bio - GlobeNewsWire
- 1 year ago - TOURMALINE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Tourmaline Bio, Inc. - TRML - Business Wire
- 1 year ago - This Small Biotech Stock Is Surging Today. Here's Why. - Investopedia
- 1 year ago - Tourmaline Bio surges after Novartis $1.4 billion acquisition; analysts see strong fit - Invezz